Tirzepatide Tirzepatide (Mounjaro, Zepbound) is the newest and most effective FDA-approved weight loss medication available
The implications of GLP-1 drugs are far-reaching: if issues of cost and access can be managed, these medications could significantly reduce the burden of type 2 diabetes, cardiovascular disease, and obesity-related complications on a global scale
We screen for kidney function, medication interactions, and absorption issues before recommending high-dose protocols, which is something a quick walk-in shot bar typically skips
Deacetylation followed by methylation of histones promoted the neural stem cells differentiation into neurons and glial cells
FDA-approved peptides (semaglutide, tirzepatide, etc.): Illegal to buy without prescription